151 related articles for article (PubMed ID: 8065455)
1. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma.
Matthews S; Barlow P; Boyd J; Barton G; Russell R; Mills H; Cunningham M; Meyers N; Burns N; Clark N
Nature; 1994 Aug; 370(6491):666-8. PubMed ID: 8065455
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein.
Massiah MA; Starich MR; Paschall C; Summers MF; Christensen AM; Sundquist WI
J Mol Biol; 1994 Nov; 244(2):198-223. PubMed ID: 7966331
[TBL] [Abstract][Full Text] [Related]
3. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
4. The p17 stretch at the N terminus of the HIV1-gag precursor and the intracellular part of HIV1-env gp41 have heptad repeat regions in their sequences that could bind to each other in a coiled coil.
Wachinger G; Nitschko H; Wachinger M; von der Helm K
Protein Seq Data Anal; 1991 Dec; 4(6):375-6. PubMed ID: 1812494
[No Abstract] [Full Text] [Related]
5. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes.
Gupta S; Arora K; Gupta A; Chaudhary VK
Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics analysis of HIV-1 matrix protein: clarifying differences between crystallographic and solution structures.
Verli H; Calazans A; Brindeiro R; Tanuri A; Guimarães JA
J Mol Graph Model; 2007 Jul; 26(1):62-8. PubMed ID: 17067836
[TBL] [Abstract][Full Text] [Related]
7. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
8. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.
Haffar OK; Popov S; Dubrovsky L; Agostini I; Tang H; Pushkarsky T; Nadler SG; Bukrinsky M
J Mol Biol; 2000 Jun; 299(2):359-68. PubMed ID: 10860744
[TBL] [Abstract][Full Text] [Related]
9. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
Tang C; Ndassa Y; Summers MF
Nat Struct Biol; 2002 Jul; 9(7):537-43. PubMed ID: 12032547
[TBL] [Abstract][Full Text] [Related]
10. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
[TBL] [Abstract][Full Text] [Related]
11. Conservative hydrophobic interdomain contacts of IFN-gamma remain in P17 matrix protein of HIV-1.
Denesyuk AI; Matthews S; Zav'yalov VP; Korpela T
APMIS; 1996 Feb; 104(2):141-6. PubMed ID: 8619916
[TBL] [Abstract][Full Text] [Related]
12. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
[TBL] [Abstract][Full Text] [Related]
13. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
Scarlata S; Ehrlich LS; Carter CA
J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
[TBL] [Abstract][Full Text] [Related]
14. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission.
Hahn T; Matala E; Chappey C; Ahmad N
AIDS Res Hum Retroviruses; 1999 Jul; 15(10):875-88. PubMed ID: 10408724
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
[TBL] [Abstract][Full Text] [Related]
17. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.
Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C
Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947
[TBL] [Abstract][Full Text] [Related]
18. Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography.
Forster MJ; Mulloy B; Nermut MV
J Mol Biol; 2000 May; 298(5):841-57. PubMed ID: 10801353
[TBL] [Abstract][Full Text] [Related]
19. Functions of the HIV-1 matrix protein p17.
Fiorentini S; Marini E; Caracciolo S; Caruso A
New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses.
Christensen AM; Massiah MA; Turner BG; Sundquist WI; Summers MF
J Mol Biol; 1996 Dec; 264(5):1117-31. PubMed ID: 9000634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
